BN Brookfield Corporation - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
BN Stock | Fundamental Analysis & Investment Insights
NYSE
Financial Services
Asset Management
Current Price
Live
$47.17
Analyst Target
$51.5
+9.2%
Upside
52W High
$49.57
52W Low
$29.07
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
65%
Analysis Accuracy
The deterministic health scores present a mixed picture: the Piotroski F-Score of 4/9 indicates borderline stable financial health, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite a high forward P/E of 8.04 suggesting reasonable future earnings expectations, the trailing P/E of 131.03 reflects significant volatility or one-time impacts. Earnings growth is highly volatile with a YoY surge of 719.20%, but recent quarters show deteriorating performance, including a -91.3% YoY EPS drop and consistent earnings misses. The stock trades well above the Graham Number of $12.39 and intrinsic value of $10.62, implying substantial premium pricing based on growth and market sentiment rather than defensive or fundamental value.
Key Strengths
High operating margin of 24.72% indicates strong cost control and pricing power within asset management
Solid balance sheet liquidity with current ratio of 1.77 and quick ratio of 1.25
Debt/equity of 1.61 is in line with sector average, suggesting acceptable leverage for financial services
Analyst recommendation consensus is 'buy' with a target price of $51.50, implying 9.1% upside
Long-term price performance is strong, with +139.4% return over 5 years
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health, particularly concerning for a financial firm
Extreme volatility in earnings with recent YoY EPS decline of 91.3% and Q/Q drop of 33.3%
Consistent failure to meet earnings estimates: 0 out of last 4 quarters beaten, with average surprise of -109.05%
Current P/E of 131.03 is extremely high, suggesting potential overvaluation or earnings distortion
Stock trades at a large premium to Graham Number ($12.39) and intrinsic value ($10.62), increasing downside risk
AI Fair Value Estimate
Based on comprehensive analysis
$35.0
-25.8% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BN against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BN from our newsroom.
Newest → oldest
No matching news yet.